Annual Results And Closure Of Register Of Members

Overview

The report presents Golden Meditech's FY2017/2018 results, including completion of the disposal of its 65.4% interest in Global Cord Blood Corporation and a HK$0.30 special cash dividend. It reports HK$250,719,000 revenue from continuing operations and describes the Group's expansion into cells and tissues storage and genetic testing. Its second ESG Report covers the Shanghai hospital and Beijing plant, identifies 12 material issues through stakeholder engagement, and reports site-level environmental and social KPIs.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2017-2018
Period: 1 April 2017 – 31 March 2018
Publication date: 27 June 2018
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services